CLASSIFICATION OF ANTIHYPERLIPIDEMIC DRUGS PDF
Antihyperlipidemic Drugs. c h a p t e r atherosclerosis bile acid sequestrants catalyst cholesterol high-density lipoproteins (HDL). HMG-CoA. Hypolipidemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used in the treatment of high levels of fats (lipids), such as cholesterol, in the blood (hyperlipidemia). They are called lipid-lowering drugs . Contents. 1 Classes. Established. 2 Research; 3 References; 4 See also. Chapter 18 Antihyperlipidemic Agents LEARNING OBJECTIVES Define hyperlipidemia and atherosclerosis, and their causes Classify antihyperlipidemics.
|Published (Last):||8 May 2012|
|PDF File Size:||16.69 Mb|
|ePub File Size:||15.87 Mb|
|Price:||Free* [*Free Regsitration Required]|
Chapter Antihyperlipidemic Agents – Medicinal Chemistry, 2nd Edition [Book]
Colesevelam Colestilan Colestipol Colestyramine Colextran. There are several classes of hypolipidemic drugs. Because these drugs increase biliary cholesterol excretion, there is a predisposition to the formation of gallstones.
Stay ahead with the world’s most comprehensive technology and business learning platform. Mechanism of action of statins PowerPoint Presentation: Adverse effect of statins PowerPoint Presentation: Because of a circadian rhythm to LDL-receptor synthesis, statins are a little more effective if given in the evening ddugs than in the morning PowerPoint Presentation: Ezetimibe has no clinically meaningful effect on the plasma concentrations of the fat-soluble vitamins A, D, and E.
Automatically changes to Flash or non-Flash embed. Familial mixed hypertriglyceridemia V: Adveres effect of fibric acid derivatives Gastrointestinal effects Lithiasis: Upload from Desktop Single File Upload.
Plasma creatine kinase levels should be determined regularly. The presentation is successfully added In Your Favorites. Clinically, the choice of an agent will depend on the patient’s cholesterol profile zntihyperlipidemic, cardiovascular riskand the liver and kidney functions of the patient, evaluated against the balancing of risks and benefits of the medications. In addition, it is the most potent antihyperlipidemic agent for raising plasma HDL levels, which is the most common indication for its clinical use.
Define hyperlipidemia and atherosclerosis, and their causes Classify antihyperlipidemics based on the structure and mode classificaation action Define HMG-CoA and its role in hyperlipidemia Define the pharmacophoric requirements of the statin class of antihyperlipidemics Describe some antihyperlipidemics obtained from fermentation process Describe the cholesterol biosynthetic pathway and its significance Define PPAR? Anti Hyperlipidemic Drugs DrNajlaa.
List of Antihyperlipidemic agents – Generics Only –
These drugs are effective in lowering plasma cholesterol levels in all types of hyperlipidemias However, patients who are homozygous for familial hypercholesterolemia lack LDL receptors and, therefore, benefit much less from treatment with these drugs. Colesevelam has fewer gastrointestinal side effects and not Impaired absorptions. Niacin nicotinic acid Mechanism of action: Hypolipidemic agentsor antihyperlipidemic agentsare a diverse group of pharmaceuticals that are used in the treatment of high levels of fats lipidssuch as cholesterol, in the blood hyperlipidemia.
Start Free Trial No credit card required. For example, some may lower the “bad cholesterol” low density lipoprotein LDL more so than others, while others may preferentially increase high density lipoprotein HDL”the good cholesterol”.
Niacin is administered orally.
Pravastatin and fluvastatin are almost completely absorbed after oral administration. Some antihyperlipidemic agents aim to lower the levels of low-density lipoprotein LDL cholesterol, some reduce triglyceride levels, and some help raise the high-density lipoprotein HDL cholesterol.
Define hyperlipidemia and atherosclerosis, and their causes. Contraindication Where hepatic or renal sntihyperlipidemic is severely impaired but gemfibrozil has been used in uraemic and nephrotic patients without aggravating deterioration in kidney function pregnant or lactating women PowerPoint Presentation: